Sorry, you need to enable JavaScript to visit this website.

Branded vs. Generic

  • Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.

  • The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.

Related Articles

Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises

Pfizer conducted a global online survey exploring the challenges of hemophilia as well as the priorities that shape treatment decisions and considerations for change.

Photograph of a bearded man in glasses talking with another person indoors, thumbnail.

Direct Relief and The Pfizer Foundation Expand Support for Community Health Centers on the Front Lines of Infectious Disease Care

This spring, Direct Relief and The Pfizer Foundation announced the third cohort of the Innovation Awards in Community Health.

Photograph of a doctor showing a medical file to a smiling patient in an exam room thumbnail

How Pfizer Thinks About AI

At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day.

Abstract blue circuitry with glowing lines and fluid, wave-like structures thumbnail

How Drugs Are Made

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Clinical Trials

Learn more about the process of joining a clinical trial and find a trial near you.

Go to Pfizer Clinical Trials Site Details